Annual CFI
-$55.56 M
+$57.79 M+50.98%
December 31, 2023
Summary
- As of February 8, 2025, ALPN annual cash flow from investing activities is -$55.56 million, with the most recent change of +$57.79 million (+50.98%) on December 31, 2023.
- During the last 3 years, ALPN annual CFI has risen by +$17.26 million (+23.70%).
Performance
ALPN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
-$2.56 M
+$110.14 M+97.73%
March 1, 2024
Summary
- As of February 8, 2025, ALPN quarterly cash flow from investing activities is -$2.56 million, with the most recent change of +$110.14 million (+97.73%) on March 1, 2024.
- Over the past year, ALPN quarterly CFI has dropped by -$2.03 million (-378.88%).
Performance
ALPN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
-$86.47 M
-$30.91 M-55.64%
March 1, 2024
Summary
- As of February 8, 2025, ALPN TTM cash flow from investing activities is -$86.47 million, with the most recent change of -$30.91 million (-55.64%) on March 1, 2024.
- Over the past year, ALPN TTM CFI has dropped by -$35.72 million (-70.37%).
Performance
ALPN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ALPN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.0% | -378.9% | -70.4% |
| 3 y3 years | +23.7% | -378.9% | -70.4% |
| 5 y5 years | -273.0% | -378.9% | -70.4% |
ALPN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +5.9% | +104.0% | -108.7% | +4299.0% | +788.3% | +31.1% |
| 5 y | 5-year | -431.4% | +104.0% | -108.7% | +4299.0% | -331.0% | +67.7% |
| alltime | all time | -273.0% | +104.0% | -108.7% | +4299.0% | -282.6% | +67.7% |
Alpine Immune Sciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$2.56 M(-97.7%) | -$86.47 M(+55.6%) |
| Dec 2023 | -$55.56 M(-51.0%) | -$112.70 M(>+9900.0%) | -$55.56 M(+9.5%) |
| Sep 2023 | - | -$535.00 K(-101.8%) | -$50.76 M(+107.8%) |
| Jun 2023 | - | $29.33 M(+3.4%) | -$24.43 M(-48.2%) |
| Mar 2023 | - | $28.35 M(-126.3%) | -$47.20 M(-58.4%) |
| Dec 2022 | -$113.35 M(+116.0%) | -$107.90 M(-518.4%) | -$113.35 M(+1064.5%) |
| Sep 2022 | - | $25.79 M(+292.9%) | -$9.73 M(-90.1%) |
| Jun 2022 | - | $6.56 M(-117.4%) | -$98.04 M(+17.1%) |
| Mar 2022 | - | -$37.80 M(+782.2%) | -$83.74 M(+59.6%) |
| Dec 2021 | -$52.48 M(-27.9%) | -$4.29 M(-93.1%) | -$52.48 M(-63.8%) |
| Sep 2021 | - | -$62.52 M(-399.6%) | -$145.04 M(+79.8%) |
| Jun 2021 | - | $20.87 M(-418.8%) | -$80.69 M(-12.8%) |
| Mar 2021 | - | -$6.55 M(-93.2%) | -$92.50 M(+27.0%) |
| Dec 2020 | -$72.82 M(-534.4%) | -$96.85 M(-5355.0%) | -$72.82 M(-356.2%) |
| Sep 2020 | - | $1.84 M(-79.7%) | $28.42 M(-24.1%) |
| Jun 2020 | - | $9.06 M(-31.0%) | $37.44 M(+246.8%) |
| Mar 2020 | - | $13.13 M(+199.2%) | $10.79 M(-35.6%) |
| Dec 2019 | $16.76 M(-47.8%) | $4.39 M(-59.6%) | $16.76 M(-22.1%) |
| Sep 2019 | - | $10.86 M(-161.8%) | $21.51 M(-18.6%) |
| Jun 2019 | - | -$17.59 M(-192.1%) | $26.42 M(-44.2%) |
| Mar 2019 | - | $19.10 M(+109.1%) | $47.35 M(+47.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $32.12 M(-207.8%) | $9.14 M(-42.1%) | $32.12 M(+29.3%) |
| Sep 2018 | - | $15.77 M(+372.6%) | $24.84 M(-166.1%) |
| Jun 2018 | - | $3.34 M(-13.7%) | -$37.57 M(+62.7%) |
| Mar 2018 | - | $3.87 M(+108.6%) | -$23.09 M(-22.5%) |
| Dec 2017 | -$29.80 M(-217.8%) | $1.85 M(-104.0%) | -$29.80 M(+61.0%) |
| Sep 2017 | - | -$46.63 M(-361.8%) | -$18.51 M(-150.9%) |
| Jun 2017 | - | $17.81 M(-727.5%) | $36.38 M(+49.0%) |
| Mar 2017 | - | -$2.84 M(-121.6%) | $24.42 M(-3.5%) |
| Dec 2016 | $25.30 M(-140.5%) | $13.15 M(+59.1%) | $25.30 M(-267.9%) |
| Sep 2016 | - | $8.27 M(+41.5%) | -$15.07 M(-74.2%) |
| Jun 2016 | - | $5.84 M(-399.5%) | -$58.47 M(-9.1%) |
| Mar 2016 | - | -$1.95 M(-92.8%) | -$64.35 M(+3.0%) |
| Dec 2015 | -$62.45 M(>+9900.0%) | -$27.23 M(-22.5%) | -$62.45 M(+77.3%) |
| Sep 2015 | - | -$35.14 M(>+9900.0%) | -$35.22 M(>+9900.0%) |
| Jun 2015 | - | -$35.00 K(-32.7%) | -$87.00 K(+58.5%) |
| Mar 2015 | - | -$52.00 K(<-9900.0%) | -$54.90 K(+1272.5%) |
| Dec 2014 | -$4000.00(-96.8%) | $0.00(0.0%) | -$4000.00(0.0%) |
| Sep 2014 | - | $0.00(-100.0%) | -$4000.00(0.0%) |
| Jun 2014 | - | -$2900.00(+163.6%) | -$4000.00(+263.6%) |
| Mar 2014 | - | -$1100.00 | -$1100.00 |
| Dec 2013 | -$125.00 K(+322.3%) | - | - |
| Dec 2012 | -$29.60 K | - | - |
FAQ
- What is Alpine Immune Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for Alpine Immune Sciences?
- What is Alpine Immune Sciences annual CFI year-on-year change?
- What is Alpine Immune Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Alpine Immune Sciences?
- What is Alpine Immune Sciences quarterly CFI year-on-year change?
- What is Alpine Immune Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Alpine Immune Sciences?
- What is Alpine Immune Sciences TTM CFI year-on-year change?
What is Alpine Immune Sciences annual cash flow from investing activities?
The current annual CFI of ALPN is -$55.56 M
What is the all time high annual CFI for Alpine Immune Sciences?
Alpine Immune Sciences all-time high annual cash flow from investing activities is $32.12 M
What is Alpine Immune Sciences annual CFI year-on-year change?
Over the past year, ALPN annual cash flow from investing activities has changed by +$57.79 M (+50.98%)
What is Alpine Immune Sciences quarterly cash flow from investing activities?
The current quarterly CFI of ALPN is -$2.56 M
What is the all time high quarterly CFI for Alpine Immune Sciences?
Alpine Immune Sciences all-time high quarterly cash flow from investing activities is $29.33 M
What is Alpine Immune Sciences quarterly CFI year-on-year change?
Over the past year, ALPN quarterly cash flow from investing activities has changed by -$2.03 M (-378.88%)
What is Alpine Immune Sciences TTM cash flow from investing activities?
The current TTM CFI of ALPN is -$86.47 M
What is the all time high TTM CFI for Alpine Immune Sciences?
Alpine Immune Sciences all-time high TTM cash flow from investing activities is $47.35 M
What is Alpine Immune Sciences TTM CFI year-on-year change?
Over the past year, ALPN TTM cash flow from investing activities has changed by -$35.72 M (-70.37%)